全国创伤性肋骨骨折手术稳定后的再入院率

Peter I. Cha, Nicholas A. Hakes, Jeff Choi, G. Rosenberg, L. Tennakoon, D. Spain, J. Forrester
{"title":"全国创伤性肋骨骨折手术稳定后的再入院率","authors":"Peter I. Cha, Nicholas A. Hakes, Jeff Choi, G. Rosenberg, L. Tennakoon, D. Spain, J. Forrester","doi":"10.4103/jctt.jctt_6_20","DOIUrl":null,"url":null,"abstract":"Introduction: Little is known about the risk of readmission after surgical stabilization of rib fractures (SSRFs). Materials and Methods: We performed a retrospective analysis of the National Readmissions Database, a representative sample of all hospitalized patients in the US, from January 2012 to December 2014. All inpatient encounters with a primary trauma diagnosis of rib fractures were included in the study. Patients who underwent SSRF were compared to those who did not. Outcomes evaluated included readmission frequency and mortality. Results: There were 411,169 patients admitted after trauma with rib fractures from 2012 to 2014; of these, 382 (<1%) underwent SSRF. Among non-SSRF patients, ≥3 rib fractures (odds ratio = 1.41, 95% confidence interval 1.23–1.62) were associated with readmission. Compared to the non-SSRF group, patients undergoing SSRF had a greater incidence of flail chest (26% vs. 2%; P < 0.0001), were more likely to have an injury severity score >15 (55% vs. 37%; P < 0.0001), and more likely to have a coexisting diagnosis of respiratory failure (35% vs. 18%, P < 0.0001). Despite the increased severity of injury among patients having SSRF, there was neither a statistically significant increase in patient deaths (<1% for SSRF vs. 4% no SSRF, P = 0.03) nor readmissions (<1% for SSRF vs. 1% for non SSRF, P = 1.0). Conclusions: Long-term readmission rates for traumatic rib fracture patients are low. If nonoperative management is pursued, the presence of ≥3 rib fractures increases the risk of readmission. Patients requiring SSRF do not have higher readmission or mortality rates despite having a higher burden of injury during their initial hospitalization, suggesting the clinical benefit of surgical fixation.","PeriodicalId":92962,"journal":{"name":"The journal of cardiothoracic trauma","volume":"5 1","pages":"16 - 21"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"National readmission rates after surgical stabilization of traumatic rib fractures\",\"authors\":\"Peter I. Cha, Nicholas A. Hakes, Jeff Choi, G. Rosenberg, L. Tennakoon, D. Spain, J. Forrester\",\"doi\":\"10.4103/jctt.jctt_6_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Little is known about the risk of readmission after surgical stabilization of rib fractures (SSRFs). Materials and Methods: We performed a retrospective analysis of the National Readmissions Database, a representative sample of all hospitalized patients in the US, from January 2012 to December 2014. All inpatient encounters with a primary trauma diagnosis of rib fractures were included in the study. Patients who underwent SSRF were compared to those who did not. Outcomes evaluated included readmission frequency and mortality. Results: There were 411,169 patients admitted after trauma with rib fractures from 2012 to 2014; of these, 382 (<1%) underwent SSRF. Among non-SSRF patients, ≥3 rib fractures (odds ratio = 1.41, 95% confidence interval 1.23–1.62) were associated with readmission. Compared to the non-SSRF group, patients undergoing SSRF had a greater incidence of flail chest (26% vs. 2%; P < 0.0001), were more likely to have an injury severity score >15 (55% vs. 37%; P < 0.0001), and more likely to have a coexisting diagnosis of respiratory failure (35% vs. 18%, P < 0.0001). Despite the increased severity of injury among patients having SSRF, there was neither a statistically significant increase in patient deaths (<1% for SSRF vs. 4% no SSRF, P = 0.03) nor readmissions (<1% for SSRF vs. 1% for non SSRF, P = 1.0). Conclusions: Long-term readmission rates for traumatic rib fracture patients are low. If nonoperative management is pursued, the presence of ≥3 rib fractures increases the risk of readmission. Patients requiring SSRF do not have higher readmission or mortality rates despite having a higher burden of injury during their initial hospitalization, suggesting the clinical benefit of surgical fixation.\",\"PeriodicalId\":92962,\"journal\":{\"name\":\"The journal of cardiothoracic trauma\",\"volume\":\"5 1\",\"pages\":\"16 - 21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of cardiothoracic trauma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jctt.jctt_6_20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of cardiothoracic trauma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jctt.jctt_6_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

引言:对肋骨骨折手术稳定后再次入院的风险知之甚少。材料和方法:我们对国家自述数据库进行了回顾性分析,该数据库是2012年1月至2014年12月美国所有住院患者的代表性样本。所有被诊断为肋骨骨折的住院患者都被纳入了研究。将接受SSRF治疗的患者与未接受SSRF的患者进行比较。评估的结果包括再次入院频率和死亡率。结果:2012年至2014年,共有411169名肋骨骨折创伤后患者入院;其中382例(15例(55%对37%;P<0.0001),更有可能同时诊断为呼吸衰竭(35%对18%,P<0.0001)。尽管SSRF患者的损伤严重程度增加,患者死亡人数没有统计学意义的增加(SSRF<1%,无SSRF为4%,P=0.03),再次入院人数也没有统计学意义(SSRF>1%,非SSRF为1%,P=0.00)。结论:创伤性肋骨骨折患者的长期再入院率较低。如果采用非手术治疗,肋骨骨折≥3处会增加再次入院的风险。需要SSRF的患者尽管在最初住院期间有更高的损伤负担,但其再次入院率或死亡率并不高,这表明手术固定的临床益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
National readmission rates after surgical stabilization of traumatic rib fractures
Introduction: Little is known about the risk of readmission after surgical stabilization of rib fractures (SSRFs). Materials and Methods: We performed a retrospective analysis of the National Readmissions Database, a representative sample of all hospitalized patients in the US, from January 2012 to December 2014. All inpatient encounters with a primary trauma diagnosis of rib fractures were included in the study. Patients who underwent SSRF were compared to those who did not. Outcomes evaluated included readmission frequency and mortality. Results: There were 411,169 patients admitted after trauma with rib fractures from 2012 to 2014; of these, 382 (<1%) underwent SSRF. Among non-SSRF patients, ≥3 rib fractures (odds ratio = 1.41, 95% confidence interval 1.23–1.62) were associated with readmission. Compared to the non-SSRF group, patients undergoing SSRF had a greater incidence of flail chest (26% vs. 2%; P < 0.0001), were more likely to have an injury severity score >15 (55% vs. 37%; P < 0.0001), and more likely to have a coexisting diagnosis of respiratory failure (35% vs. 18%, P < 0.0001). Despite the increased severity of injury among patients having SSRF, there was neither a statistically significant increase in patient deaths (<1% for SSRF vs. 4% no SSRF, P = 0.03) nor readmissions (<1% for SSRF vs. 1% for non SSRF, P = 1.0). Conclusions: Long-term readmission rates for traumatic rib fracture patients are low. If nonoperative management is pursued, the presence of ≥3 rib fractures increases the risk of readmission. Patients requiring SSRF do not have higher readmission or mortality rates despite having a higher burden of injury during their initial hospitalization, suggesting the clinical benefit of surgical fixation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信